Half-year report · Q2
7732.TEDINET S100UKCN
Period2024-04-01 → 2024-09-30
Filed2024-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥105.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥216.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥104.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥3.0bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥3.8bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥381m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥8.9bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.4bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥381m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.0bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥61m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.9bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥609m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥76m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥756m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥238.6bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥247.0bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥238.6bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥134.4bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥136.7bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥104.2bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥110.3bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥105.1bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥19.3bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥19.6bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥16.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥16.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥17.4bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.9bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥5.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.3bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥6.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥26.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥17.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥18.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥15.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥0.58 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.9 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.78 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥0.58 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥46.89 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥5.78 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 42.9% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.8% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.3% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2024-04-01 → 2024-09-30 | ¥248m |
| Otherother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥248m |
| Otherother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥0 |
| Otherother segments | segment profit | 2024-04-01 → 2024-09-30 | −¥271m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥35m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥35m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥2.2bn |
| jpcrp040300-q2r_E02299-000Eye Care Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥37.1bn |
| jpcrp040300-q2r_E02299-000Eye Care Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥37.1bn |
| jpcrp040300-q2r_E02299-000Eye Care Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥35m |
| jpcrp040300-q2r_E02299-000Eye Care Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E02299-000Positioning Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥68.2bn |
| jpcrp040300-q2r_E02299-000Positioning Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥68.2bn |
| jpcrp040300-q2r_E02299-000Positioning Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥0 |
| jpcrp040300-q2r_E02299-000Positioning Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥4.1bn |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥105.5bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥105.5bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥35m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥5.2bn |
| Otherother segments | revenue | 2023-04-01 → 2023-09-30 | ¥625m |
| Otherother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥623m |
| Otherother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥2m |
| Otherother segments | segment profit | 2023-04-01 → 2023-09-30 | −¥91m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥143m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥143m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥2.2bn |
| jpcrp040300-q2r_E02299-000Eye Care Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥34.5bn |
| jpcrp040300-q2r_E02299-000Eye Care Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥34.3bn |
| jpcrp040300-q2r_E02299-000Eye Care Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥134m |
| jpcrp040300-q2r_E02299-000Eye Care Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E02299-000Positioning Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥69.6bn |
| jpcrp040300-q2r_E02299-000Positioning Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥69.6bn |
| jpcrp040300-q2r_E02299-000Positioning Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥5m |
| jpcrp040300-q2r_E02299-000Positioning Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥4.9bn |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥104.6bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥104.5bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥143m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥6.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 510
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | Prior1YTDDuration | 104497000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02299-000PositioningBusinessReportableSegmentMember | 5000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02299-000EyeCareBusinessReportableSegmentMember | 134000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_OtherReportableSegmentsMember | 2000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 143000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -143000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02299-000PositioningBusinessReportableSegmentMember | 69563000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02299-000EyeCareBusinessReportableSegmentMember | 34451000000 | JPY |
| Net sales | Prior1YTDDuration_OtherReportableSegmentsMember | 625000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 104640000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -143000000 | JPY |
| Net sales | Prior1YTDDuration | 104497000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02299-000PositioningBusinessReportableSegmentMember | 4862000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02299-000EyeCareBusinessReportableSegmentMember | 1269000000 | JPY |
| Operating income | Prior1YTDDuration_OtherReportableSegmentsMember | -91000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 6040000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -2209000000 | JPY |
| Operating income | Prior1YTDDuration | 3830000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02299-000PositioningBusinessReportableSegmentMember | 68179000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02299-000EyeCareBusinessReportableSegmentMember | 37070000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OtherReportableSegmentsMember | 248000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 105497000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 105497000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02299-000PositioningBusinessReportableSegmentMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02299-000EyeCareBusinessReportableSegmentMember | 35000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_OtherReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 35000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -35000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02299-000PositioningBusinessReportableSegmentMember | 68179000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02299-000EyeCareBusinessReportableSegmentMember | 37105000000 | JPY |
| Net sales | CurrentYTDDuration_OtherReportableSegmentsMember | 248000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 105533000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -35000000 | JPY |
| Net sales | CurrentYTDDuration | 105497000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02299-000PositioningBusinessReportableSegmentMember | 4059000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02299-000EyeCareBusinessReportableSegmentMember | 1378000000 | JPY |
| Operating income | CurrentYTDDuration_OtherReportableSegmentsMember | -271000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 5166000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -2192000000 | JPY |
| Operating income | CurrentYTDDuration | 2974000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-11-11 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第132期中(自 2024年４月１日 至 2024年９月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社トプコン | |
| Company name in english cover page | FilingDateInstant | TOPCON CORPORATION |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |